| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Crispr Therapeutics AG (CRSP) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 20 sells. CRSP is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 255.5K | $14.28M | - | |
| Dir | 22.0K | $1.23M | - | |
| CFO | 19.5K | $1.09M | - | |
| Other | 19.4K | $1.08M | -3,786 | |
| Other | 17.0K | $950.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 12, 2024 | Kasinger James R.61 | General Counsel And Secretary | Sale+OE | 3,947 | $77.15 | $304,514.50 | -3.2% | -20.3% | -42.2% | |
| Mar 12, 2024 | Kulkarni Samarth68 | Chief Executive Officer | Sale+OE | 14,385 | $77.04 | $1,108,263.04 | -3.4% | -20.3% | -42.2% | |
| Feb 20, 2024 | Kasinger James R.61 | General Counsel And Secretary | Sale+OE | 1,913 | $79.67 | $152,408.71 | -3.2% | -29.5% | -32.7% | |
| Feb 20, 2024 | Kulkarni Samarth68 | Chief Executive Officer | Sale+OE | 6,370 | $79.67 | $507,497.90 | -3.2% | -29.5% | -32.7% | |
| Feb 15, 2024 | Kulkarni Samarth68 | Chief Executive Officer | Sale+OE | 20,000 | $80.36 | $1,607,177.46 | -3.4% | -32.6% | -41.1% | |
| Jan 29, 2024 | Kulkarni Samarth68 | Chief Executive Officer | Sale+OE | 50,000 | $60.51 | $3,025,572.69 | -11.8% | -16.6% | -36.4% | |
| Jan 16, 2024 | Kulkarni Samarth68 | Chief Executive Officer | Sale+OE | 20,000 | $62.50 | $1,250,058.00 | -9.6% | -7.4% | -38.5% | |
| May 30, 2023 | Kulkarni Samarth68 | Chief Executive Officer | Sale+OE | 25,000 | $64.88 | $1,621,894.25 | -1.6% | -22.7% | -16.7% | |
| Apr 25, 2023 | Kulkarni Samarth68 | Chief Executive Officer | Sale+OE | 25,000 | $50.67 | $1,266,637.58 | -3.1% | +12.3% | +12.6% | |
| Mar 29, 2023 | Kulkarni Samarth68 | Chief Executive Officer | Sale+OE | 25,000 | $44.46 | $1,111,503.52 | -3.1% | +23.6% | +50.9% |